Glimepiride CAS 93479-97-1 Assay 98.0% ~ 102.0% API Iwa mimọ giga

Apejuwe kukuru:

Orukọ Kemikali: Glimepiride

CAS: 93479-97-1

Irisi: Funfun tabi Fere Funfun Powder

Ayẹwo: 98.0% ~ 102.0%

Glimepiride ni itọju ti Noninsulin-Igbẹkẹle Iru 2 Àtọgbẹ mellitus

API Didara Giga, Iṣelọpọ Iṣowo

Inquiry: alvin@ruifuchem.com


Alaye ọja

Jẹmọ Products

ọja Tags

Apejuwe:

Ipese pẹlu Iwa mimọ giga ati Didara Idurosinsin
Orukọ Kemikali: Glimepiride
CAS: 93479-97-1
Glimepiride ni itọju ti Noninsulin-Igbẹkẹle Iru 2 Àtọgbẹ mellitus
API Didara Giga, Iṣelọpọ Iṣowo

Kemikali Properties:

Orukọ Kemikali Glimepiride
Awọn itumọ ọrọ sisọ Amaryl
Nọmba CAS 93479-97-1
NỌMBA CAT RF-API24
Iṣura Ipo Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn Toonu
Fọọmu Molecular C24H34N4O5S
Òṣuwọn Molikula 490.62
Ojuami Iyo 212.2 ~ 214.5 ℃
Sowo Ipò Labẹ Ibaramu otutu
Brand Ruifu Kemikali

Awọn pato:

Nkan Awọn pato
Ifarahan Funfun tabi Fere Funfun Powder
Idanimọ IR (Ti o jọra si Standard)
Awọn nkan ti o jọmọ
Cis-Isomer (A) ≤0.80%
Sulfonamide (B) ≤0.40%
Urethane (C) ≤0.10%
3-Isomer (D) ≤0.20%
Eyikeyi Iwa Aimọ ≤0.10%
Lapapọ Awọn Aimọ ≤0.50%
Pipadanu lori Gbigbe ≤0.50%
Aloku lori Iginisonu ≤0.10%
Awọn irin Heavy ≤0.001%
Ayẹwo 98.0% ~ 102.0%
Igbeyewo Standard European Pharmacopeia (EP);Orilẹ Amẹrika Pharmacopoeia (USP)
Lilo Ohun elo elegbogi ti nṣiṣe lọwọ (API)

Package & Ibi ipamọ:

Package: Igo, apo apamọwọ Aluminiomu, ilu paali, 25kg / Drum, tabi gẹgẹbi ibeere alabara.

Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina, ọrinrin ati kokoro infestation.

Awọn anfani:

1

FAQ:

Ohun elo:

Shanghai Ruifu Kemikali Co., Ltd jẹ olupilẹṣẹ asiwaju ati olupese ti Glimepiride (CAS: 93479-97-1) pẹlu didara to gaju, eroja elegbogi ti nṣiṣe lọwọ (API).Glimepiride jẹ oogun apakokoro ti o ṣe iranlọwọ lati ṣakoso awọn ipele suga ẹjẹ.Glimepiride jẹ iṣẹ ṣiṣe pipẹ, sulfonylurea iran-kẹta pẹlu iṣẹ ṣiṣe hypoglycemic.

Glimepiride (orukọ iṣowo akọkọ Amaryl) jẹ oogun oogun antidiabetic sulfonylurea ti o wa ni aarin-si-gun.Gẹgẹbi gbogbo sulfonylureas, glimepiride n ṣiṣẹ bi aṣiri insulini.O dinku suga ẹjẹ nipasẹ safikun itusilẹ ti hisulini lati awọn sẹẹli beta pancreatic ti n ṣiṣẹ ati nipa jijẹ ifamọ ti awọn sẹẹli agbeegbe si hisulini.Glimepiride ṣee ṣe sopọ mọ awọn olugba potasiomu ti o ni ifaramọ ATP lori dada sẹẹli pancreatic, idinku iṣesi potasiomu ati nfa depolarization ti awọ ara.Depolarization Membrane n ṣe influx kalisiomu ion nipasẹ awọn ikanni kalisiomu ti o ni imọlara foliteji.Ilọsoke ninu ifọkansi ion kalisiomu intracellular jẹ ki yomijade ti hisulini.A lo Glimepiride ni akọkọ lati tọju awọn alaisan ti o ni àtọgbẹ iru 2 ati pe o tun le dinku awọn aye ti ẹnikan yoo dagbasoke awọn ilolu ti àtọgbẹ iru 2.Oogun naa jẹ ifọwọsi nipasẹ FDA ni ọdun 1995 ati pe o jẹ iṣelọpọ nipasẹ Sanofi-Aventis.O le ṣee lo pẹlu ounjẹ to dara ati eto idaraya ati pe o tun le ṣee lo nikan tabi pẹlu awọn oogun antidiabetic miiran ti o ba nilo.Glimepiride le ṣee lo boya bi monotherapy tabi ni apapo pẹlu hisulini.

Kọ ifiranṣẹ rẹ nibi ki o si fi si wa